These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 3946461)

  • 21. Routine cholesterol surveillance in childhood.
    Garcia RE; Moodie DS
    Pediatrics; 1989 Nov; 84(5):751-5. PubMed ID: 2640549
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cholesterol and coronary artery disease. What do clinicians do now?
    Levy RI
    Am J Med; 1986 Feb; 80(2A):18-22. PubMed ID: 3946457
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlates and consequences of diffuse atherosclerosis in men with coronary heart disease. Veterans Affairs High-Density Lipoprotein Intervention Trial Study Group.
    Wilt TJ; Rubins HB; Collins D; O'Connor TZ; Rutan GH; Robins SJ
    Arch Intern Med; 1996 Jun; 156(11):1181-8. PubMed ID: 8639012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aggressive cholesterol lowering delays saphenous vein graft atherosclerosis in women, the elderly, and patients with associated risk factors. NHLBI post coronary artery bypass graft clinical trial. Post CABG Trial Investigators.
    Campeau L; Hunninghake DB; Knatterud GL; White CW; Domanski M; Forman SA; Forrester JS; Geller NL; Gobel FL; Herd JA; Hoogwerf BJ; Rosenberg Y
    Circulation; 1999 Jun; 99(25):3241-7. PubMed ID: 10385497
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention of coronary heart disease through cholesterol reduction.
    Grundy SM
    Am Fam Physician; 1997 May; 55(6):2250-8. PubMed ID: 9149652
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does lowering serum cholesterol levels lower coronary heart disease risk?
    Rossouw JE; Rifkind BM
    Endocrinol Metab Clin North Am; 1990 Jun; 19(2):279-97. PubMed ID: 2192874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The influence of changes in lipid values induced by cholestyramine and diet on progression of coronary artery disease: results of NHLBI Type II Coronary Intervention Study.
    Levy RI; Brensike JF; Epstein SE; Kelsey SF; Passamani ER; Richardson JM; Loh IK; Stone NJ; Aldrich RF; Battaglini JW
    Circulation; 1984 Feb; 69(2):325-37. PubMed ID: 6360415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LDL cholesterol lowering by bile acid malabsorption during inhibited synthesis and absorption of cholesterol in hypercholesterolemic coronary subjects.
    Gylling H; Miettinen TA
    Nutr Metab Cardiovasc Dis; 2002 Feb; 12(1):19-23. PubMed ID: 12125225
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipids and hypertension. Implications of new guidelines for cholesterol management in the treatment of hypertension.
    Grimm RH; Hunninghake DB
    Am J Med; 1986 Feb; 80(2A):56-63. PubMed ID: 3946462
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence and prognostic significance of hypercholesterolemia in men with hypertension. Prospective data on the primary screenees of the Multiple Risk Factor Intervention Trial.
    Stamler J; Wentworth D; Neaton JD
    Am J Med; 1986 Feb; 80(2A):33-9. PubMed ID: 3946459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identifying patients at risk for coronary heart disease: implications from trials of lipid-lowering drug therapy.
    Isles CG; Paterson JR
    QJM; 2000 Sep; 93(9):567-74. PubMed ID: 10984551
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of exercise in reducing coronary heart disease and associated risk factors.
    Leclerc KM
    J Okla State Med Assoc; 1992 Jun; 85(6):283-90. PubMed ID: 1474418
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cardiovascular risk factors and prevention in women: similarities and differences].
    Sclavo M
    Ital Heart J Suppl; 2001 Feb; 2(2):125-41. PubMed ID: 11255880
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lipoproteins and coronary heart disease.
    Krauss RM
    Postgrad Med; 1989 Apr; Spec No():54-8; discussion 89-90. PubMed ID: 2726627
    [No Abstract]   [Full Text] [Related]  

  • 35. Can modification of risk factors reduce coronary heart disease?
    Grundy SM
    Cardiovasc Clin; 1983; 13(1):283-96. PubMed ID: 6336670
    [No Abstract]   [Full Text] [Related]  

  • 36. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
    Cziraky MJ; Watson KE; Talbert RL
    J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Significance of hypercholesterolemia for epidemiology, prevention and pathogenesis of coronary heart diseases].
    Gohlke H
    Dtsch Med Wochenschr; 1989 Dec; 114(50):1974-8. PubMed ID: 2689125
    [No Abstract]   [Full Text] [Related]  

  • 38. [Primary prevention of coronary disease by modification of the lipids].
    Augustin J
    Dtsch Med Wochenschr; 1984 Jun; 109(24):965-7. PubMed ID: 6376043
    [No Abstract]   [Full Text] [Related]  

  • 39. [Preventing arteriosclerotic coronary disease by changing the diet and mode of life].
    Stamler J; Mojonnier L; Hall Y; Berkson D; Lindberg H
    Kardiologiia; 1971 May; 11(5):26-39. PubMed ID: 5126315
    [No Abstract]   [Full Text] [Related]  

  • 40. Secondary prevention and lipid lowering: results and implications.
    Detre KM; Levy RI; Kelsey SF; Epstein SE; Brensike JF; Passamani ER; Richardson JM; Loh IK; Stone NJ; Aldrich RF
    Am Heart J; 1985 Nov; 110(5):1123-7. PubMed ID: 3904378
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.